Biogenic Silver Nanoparticles As Antifungal Agents

Overview

Journal Front Chem

Specialty Chemistry

Date 2022 Oct 24

PMID 36277355

Authors

Javier Mussin

Gustavo Giusiano

Affiliations

Soon will be listed here.

Abstract

In recent years, an increase in multidrug-resistant fungal strains has been observed, which, together with the limited number of clinically available antifungal agents, highlights the need for the development of new antifungal agents. Due to the proven antifungal activity of silver nanoparticles (AgNPs), there is a growing interest in their use in the treatment of fungal infections. Nanoparticles are usually synthesised through a variety of physical and chemical processes that are costly and pollute the environment. For this reason, biogenic synthesis is emerging as an environmentally friendly technology and new strategies are increasingly based on the use of biogenic AgNPs as antifungal agents for clinical use. The aim of this review is to compare the antifungal activity of different biogenic AgNPs and to summarise the current knowledge on the mechanisms of action and resistance of fungi to AgNPs. Finally, a general analysis of the toxicity of biogenic AgNPs in human and veterinary medicine is performed.

Citing Articles

Extracellular Biosynthesis, Characterization and Antimicrobial Activity of Silver Nanoparticles Synthesized by Filamentous Fungi.

Raut I, Constantin M, Suica-Bunghez R, Firinca C, Alexandrescu E, Gifu I J Fungi (Basel). 2024; 10(11).

PMID: 39590717 PMC: 11595898. DOI: 10.3390/jof10110798.

Nanotechnology in action: silver nanoparticles for improved eco-friendly remediation.

Krishna S, Sheik A, Pillay K, Ahmed Hamza M, Elamir M, Selim S PeerJ. 2024; 12:e18191.

PMID: 39372718 PMC: 11456292. DOI: 10.7717/peerj.18191.

Unlocking the Potential of Silver Nanoparticles: From Synthesis to Versatile Bio-Applications.

Almatroudi A Pharmaceutics. 2024; 16(9).

PMID: 39339268 PMC: 11435049. DOI: 10.3390/pharmaceutics16091232.

The antimicrobial effects of silver nanoparticles obtained through the royal jelly on the yeasts Candida guilliermondii NP-4.

Marutyan S, Karapetyan H, Khachatryan L, Muradyan A, Marutyan S, Poladyan A Sci Rep. 2024; 14(1):19163.

PMID: 39160246 PMC: 11333486. DOI: 10.1038/s41598-024-70197-w.

Synergistic Antimicrobial Activity of Biogenic Silver Nanoparticles and Essential Oil against Skin Infection Pathogens.

Mussin J, Giusiano G Antibiotics (Basel). 2024; 13(7).

PMID: 39061356 PMC: 11274195. DOI: 10.3390/antibiotics13070674.

References

Antsotegi-Uskola M, Markina-Inarrairaegui A, Ugalde U . Copper Resistance in Relies on the P-Type ATPase CrpA, Regulated by the Transcription Factor AceA. Front Microbiol. 2017; 8:912. PMC: 5447758. DOI: 10.3389/fmicb.2017.00912. View

Xue B, He D, Gao S, Wang D, Yokoyama K, Wang L . Biosynthesis of silver nanoparticles by the fungus Arthroderma fulvum and its antifungal activity against genera of Candida, Aspergillus and Fusarium. Int J Nanomedicine. 2016; 11:1899-906. PMC: 4862354. DOI: 10.2147/IJN.S98339. View

Chandrika K, Sharma S . Promising antifungal agents: A minireview. Bioorg Med Chem. 2020; 28(7):115398. DOI: 10.1016/j.bmc.2020.115398. View

Du H, Bing J, Hu T, Ennis C, Nobile C, Huang G . Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 2020; 16(10):e1008921. PMC: 7581363. DOI: 10.1371/journal.ppat.1008921. View

Gulbagca F, Ozdemir S, Gulcan M, Sen F . Synthesis and characterization of -mediated biogenic silver nanoparticles for anti-oxidant, antibacterial, antifungal, and DNA cleavage activities. Heliyon. 2019; 5(12):e02980. PMC: 6906675. DOI: 10.1016/j.heliyon.2019.e02980. View

Parthiban E, Manivannan N, Ramanibai R, Mathivanan N . Green synthesis of silver-nanoparticles from leaves aqueous extract and its mosquito larvicidal and anti-microbial activity on human pathogens. Biotechnol Rep (Amst). 2018; 21:e00297. PMC: 6297187. DOI: 10.1016/j.btre.2018.e00297. View

Vest K, Leary S, Winge D, Cobine P . Copper import into the mitochondrial matrix in Saccharomyces cerevisiae is mediated by Pic2, a mitochondrial carrier family protein. J Biol Chem. 2013; 288(33):23884-92. PMC: 3745335. DOI: 10.1074/jbc.M113.470674. View

Ahamad I, Bano F, Anwer R, Srivastava P, Kumar R, Fatma T . Antibiofilm Activities of Biogenic Silver Nanoparticles Against . Front Microbiol. 2022; 12:741493. PMC: 8782275. DOI: 10.3389/fmicb.2021.741493. View

Garibo D, Borbon-Nunez H, de Leon J, Garcia Mendoza E, Estrada I, Toledano-Magana Y . Green synthesis of silver nanoparticles using Lysiloma acapulcensis exhibit high-antimicrobial activity. Sci Rep. 2020; 10(1):12805. PMC: 7393152. DOI: 10.1038/s41598-020-69606-7. View

10.

Chwalibog A, Sawosz E, Hotowy A, Szeliga J, Mitura S, Mitura K . Visualization of interaction between inorganic nanoparticles and bacteria or fungi. Int J Nanomedicine. 2011; 5:1085-94. PMC: 3023237. DOI: 10.2147/IJN.S13532. View

11.

Siddiqi K, Husen A, Rao R . A review on biosynthesis of silver nanoparticles and their biocidal properties. J Nanobiotechnology. 2018; 16(1):14. PMC: 5815253. DOI: 10.1186/s12951-018-0334-5. View

12.

Hwang I, Lee J, Hwang J, Kim K, Lee D . Silver nanoparticles induce apoptotic cell death in Candida albicans through the increase of hydroxyl radicals. FEBS J. 2012; 279(7):1327-38. DOI: 10.1111/j.1742-4658.2012.08527.x. View

13.

Yehia R, Al-Sheikh H . Biosynthesis and characterization of silver nanoparticles produced by Pleurotus ostreatus and their anticandidal and anticancer activities. World J Microbiol Biotechnol. 2014; 30(11):2797-803. DOI: 10.1007/s11274-014-1703-3. View

14.

Mujaddidi N, Nisa S, Al Ayoubi S, Bibi Y, Khan S, Sabir M . Pharmacological properties of biogenically synthesized silver nanoparticles using endophyte extract of against oxidative stress and pathogenic multidrug-resistant bacteria. Saudi J Biol Sci. 2021; 28(11):6432-6440. PMC: 8568839. DOI: 10.1016/j.sjbs.2021.07.009. View

15.

Patra J, Baek K . Antibacterial Activity and Synergistic Antibacterial Potential of Biosynthesized Silver Nanoparticles against Foodborne Pathogenic Bacteria along with its Anticandidal and Antioxidant Effects. Front Microbiol. 2017; 8:167. PMC: 5309230. DOI: 10.3389/fmicb.2017.00167. View

16.

Aboelmaati M, Abdel Gaber S, Soliman W, Elkhatib W, Abdelhameed A, Sahyon H . Biogenic and biocompatible silver nanoparticles for an apoptotic anti-ovarian activity and as polydopamine-functionalized antibiotic carrier for an augmented antibiofilm activity. Colloids Surf B Biointerfaces. 2021; 206:111935. DOI: 10.1016/j.colsurfb.2021.111935. View

17.

Denning D, Perlin D, Muldoon E, Colombo A, Chakrabarti A, Richardson M . Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities. Emerg Infect Dis. 2016; 23(2):177-183. PMC: 5324810. DOI: 10.3201/eid2302.152042. View

18.

Terzioglu E, Alkim C, Arslan M, Balaban B, Holyavkin C, Kisakesen H . Genomic, transcriptomic and physiological analyses of silver-resistant Saccharomyces cerevisiae obtained by evolutionary engineering. Yeast. 2021; 37(9-10):413-426. DOI: 10.1002/yea.3514. View

19.

Pereira L, Dias N, Carvalho J, Fernandes S, Santos C, Lima N . Synthesis, characterization and antifungal activity of chemically and fungal-produced silver nanoparticles against Trichophyton rubrum. J Appl Microbiol. 2014; 117(6):1601-13. DOI: 10.1111/jam.12652. View

20.

Khan I, Bahuguna A, Krishnan M, Shukla S, Lee H, Min S . The effect of biogenic manufactured silver nanoparticles on human endothelial cells and zebrafish model. Sci Total Environ. 2019; 679:365-377. DOI: 10.1016/j.scitotenv.2019.05.045. View